Project Abstract

Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that play crucial roles in post-transcriptional gene regulation. Dysregulation of miRNAs has been implicated in various diseases, including cancer. In this study, we investigated the role of miRNAs in regulating gene expression in cancer cells, with a focus on understanding how miRNAs contribute to the development and progression of cancer. The research involved a comprehensive analysis of miRNA expression profiles in cancer cells compared to normal cells. Through bioinformatics tools and experimental validation techniques, we identified specific miRNAs that were differentially expressed in cancer cells. Functional studies were conducted to investigate the impact of these miRNAs on gene expression and cellular processes associated with cancer development. Furthermore, the study explored the molecular mechanisms through which miRNAs regulate gene expression in cancer cells. By examining the interactions between miRNAs and their target mRNAs, we elucidated the pathways and networks affected by dysregulated miRNAs in cancer. These findings shed light on the intricate regulatory networks that drive cancer progression and provide potential therapeutic targets for intervention. The results of this research contribute to a better understanding of the role of miRNAs in cancer biology and provide insights into novel strategies for cancer diagnosis and treatment. By uncovering the intricate interplay between miRNAs and gene expression in cancer cells, this study offers new perspectives on the molecular mechanisms underlying cancer development and progression. Overall, this research enhances our knowledge of the regulatory functions of miRNAs in cancer and highlights the potential for miRNA-based therapies in the management of cancer. The findings of this study have implications for personalized medicine approaches and the development of targeted therapies that exploit the dysregulated miRNA networks in cancer cells. Keywords microRNAs, gene expression, cancer cells, regulatory networks, molecular mechanisms, personalized medicine, targeted therapy.

Project Overview